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Abstract
Increasing silver nanoparticle (AgNP) use in sprays, consumer products and medical devices has 
raised concerns about potential health effects. While previous studies have investigated AgNPs, 
most were limited to a single particle size or surface coating. In this study, we investigated the 
effect of size, surface coating and dose on the persistence of silver in the lung following exposure 
to AgNP. Adult male rats were intratracheally instilled with four different AgNPs: 20 or 110nm in 
size and coated with either citrate or polyvinylpyrrolidone (PVP) at 0.5 or 1.0mg/kg doses. Silver 
retention was assessed in the lung at 1, 7 and 21 days post exposure. ICP-MS quantification 
demonstrated that citrate coated AgNPs persisted in the lung to 21 days with greater than 90% 
retention, while PVP coated AgNP had less than 30% retention. Localization of silver in lung 
tissue at one day post exposure demonstrated decreased silver in proximal airways exposed to 
110nm particles compared with 20nm AgNPs. In terminal bronchioles one day post exposure, 
silver was localized to surface epithelium but was more prominent in the basement membrane at 7 
days. Silver positive macrophages in bronchoalveolar lavage fluid decreased more quickly after 
exposure to particles coated with PVP. We conclude that PVP coated AgNPs had less retention in 
the lung tissue over time and larger particles were more rapidly cleared from large airways than 
smaller particles. The 20nm citrate particles the greatest effect; increasing lung macrophages even 
21days after exposure and resulted in the greatest silver retention in lung tissue.
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Silver nanoparticles (AgNPs) are used as anti-microbial agents in wound dressings, sprays, 
textiles and medical devices (Pelgrift, 2013). The increasing prevalence of AgNPs has led to 
concerns about accumulation in the environment as well as possible health effects (Fabrega, 
2011, Seltenrich, 2013). Further, because AgNPs are small, there is concern about 
persistence of these materials in the body following multiple routes of exposure, including 
exposures to the respiratory system. Inhalation has been proposed as a route of exposure 
during production of these materials but also during use of sprays (Quadros, 2010).
Previous work on the distribution of AgNPs in the respiratory system has been limited to 
studies that examine a single nanoparticle surface coating or size. The bulk of previous 
studies do not describe the distribution of the particles within the lung or measure the 
amount of silver retained in the lungs over time. Studies that compare inhalation versus 
instillation of insoluble particles have shown clearance of instilled particles is slower than 
for inhaled particles (Pritchard, 1985) and that biological effects may be larger for instilled 
particles at the same delivered dose (Baisch, 2014). Instillation enables screening of a large 
number of compounds, at a range of doses including high doses, rapidly and delivery of a 
readily quantifiable, known delivered dose (Driscoll, 2000). All of these features are 
advantageous for measurement of particle retention and eventual clearance from the lungs 
over time, especially when sensitivity of the measurement is required.
One mechanism of removal of particles in the lung is uptake by inflammatory cells. As 
clearance of particles is dependent on both the mucociliary escalator, as well as phagocytes, 
for removal of particles, use of multiple doses to characterize retention and distribution is 
important as these processes may be saturable. Macrophages are the predominant 
inflammatory phagocytic cell type resident and recruited to the lung, often comprising 98% 
or more of the cells obtained in bronchoalveolar lavage. Hence, when studying long term 
clearance of nanoparticles from the lung tissue, assessment of macrophage involvement is 
key to fully understanding the response.
Ag nanomaterials can be stabilized using surface coatings to prevent oxidation and loss of 
Ag ions. Citrate and polyvinylpyrrolidone (PVP) are common surface coatings used to 
stabilize AgNPs in solution (Huynh, 2011). Surface absorbed PVP stabilizes AgNPs by 
steric repulsion (Huynh, 2011). While PVP is generally considered safe by the US Food and 
Drug Administration, there have been documented cases of allergic reaction to PVP 
(Yoshida, 2008, Adachi, 2003, Rönnau, 2000). Previous studies of both citrate and PVP 
stabilized AgNPs administered in vitro, and in mice in vivo, have found that silver 
associated with small (20nm) citrate coated AgNPs were still detected in the lung tissue, 
associated with extracellular matrix, at 40 hours and 21 days after a single instillation 
(Wang, 2014). However, the effect of varying doses on the localization of AgNPs by lung 
region, and within lung cells, was not described.
In the lung, the effect of materials on the respiratory tract is greatly influenced by the lung 
region that receives the highest deposition (local delivered dose). Retention may also be 
very important for AgNPs because the nature of these particles may change over time, 
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potentially releasing silver ions (Wang, 2014). We used two doses and 4 types of AgNPs: 
citrate coated 20 and 100 nm AgNPs and PVP coated 20 and 100 nm AgNPs as well as site 
specific histopathology to evaluate AgNPs effects by lung region. We coupled this 
histologic approach with quantitative analysis of total lung silver burden over time following 
a single acute exposure. The goal was to determine: 1) how size and surface coating 
influence silver retention in the lung 2) where in the lung the silver was retained and 
whether that changed over time and 3) the extent of macrophage involvement in silver 
clearance over time. This data will inform future studies of health effects of AgNPs health 
effects in the lung because biological effects within the lung tissue can be discussed in terms 
of clearance and retention of the initial dose.
METHODS
Silver nanoparticles
Silver nanoparticles (AgNPs) manufactured by nanoComposix, Inc (San Diego, CA) were 
supplied by the National Institute of Environmental Health Sciences Centers for 
Nanotechnology Health Implications Research (NCNHIR) consortium. Preliminary testing 
and characterization of the materials was performed by The Nanotechnology 
Characterization Laboratory (SAIC-Fredrick, Frederick, MD) (Wang, 2014). Two sizes, 20 
nm and 110 nm, were used and were stabilized in two different buffers, citrate and 
polyvinylpyrrolidone (PVP) to yield 4 test particles that were delivered intratracheally (i.t.) 
as 0.5 and 1.0 mg/kg. Doses were chosen to match those used in previous studies performed 
by NCNHIR consortium members to allow comparison across studies (Wang, 2014). Two 
PVP buffers were used as controls for the PVP coated particles: 10kDa PVP (ISP 
Technologies Inc., Texas City, TX) for the 20 nm Ag NPs and 40kDA PVP (Calbiochem, 
San Diego, CA) for the 110 nm AgNPs. Sham controls included use of endotoxin free water 
with the coating material at a similar concentration to that in the AgNP suspensions so that 
effects of the coating could be separated from AgNP effects. The PVP was used at 33 μg/ml 
for the 10 kDa PVP and 62 μg/ml for the 40 kDa PVP. Citrate buffer was prepared using 
trisodium citrate dihydrate (Sigma, St. Louis, MO) in endotoxin free water to a 
concentration of 2 mM and pH 7.5. All AgNPs were supplied at 1mg/ml and dilution of 0.5 
mg/ml was made by mixing the provided AgNP suspensions with the corresponding buffers. 
AgNP stock suspensions were sonicated in a Branson Ultrasonics 8510 bath sonicator 
(Danbury, CT) for five minutes immediately prior to use.
AgNP Characterization
Dynamic Light Scattering (DLS) and Transmission Electron Microscopy (TEM) was 
performed to characterize AgNPs prior to use. DLS was performed on samples diluted 1:100 
in milliQ water with a Zetasizer Nanosizer ZEN1690 (Malvern Instruments, UK) equipped 
with a He-Ne 633 nm laser. Diluted sample absorbance was determined using a PharmaSpec 
UV-1700 spectrophotometer (Shimadzu, Santa Clara, CA) and the refractive index of silver 
was obtained from the NIST database (Smith, 1995). TEM sample grids were by prepared 
by drop-coating the sample solution onto the Lacey Carbon Type - A, 300 mesh Cu grids 
(Ted Pella Inc, Redding CA). Briefly, 6 μL of aqueous sample was placed on the TEM grid 
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and allowed to dry for 2 hours. Imaging was performed using Phillips CM12 Transmission 
Electron Microscope at 100kV.
Animals
Twelve week old male Sprague-Dawley rats were obtained from Harlan Laboratories 
(Hayward, CA) and acclimated for one week prior to treatment. Rats were housed two per 
cage and provided Laboratory Rodent Diet (Purina Mills, St Louis, MO) and water ad 
libitum. All animal experiments were performed under protocols approved by the University 
of California Davis IACUC in accordance with National Institutes of Health guidelines. For 
intratracheal instillation, rats were instilled with 1 μl/g body weight of AgNP suspension or 
vehicle control buffer under anesthesia administered via a Quantiflex anesthesia unit 
(Medmark Crop., Versailles, OH). The anesthesia unit was equipped with an isoflurane 
vaporizer using 3% isoflurane in an oxygen flow of 1.0 l/min for 5 to 6 minutes. Biological 
samples were obtained at necropsy 1, 7 and 21 days post instillation following anesthesia 
with Beuthanasia-D at 7.5 ml/Kg and exsanquination. The trachea was cannulated and left 
lung lobe isolated by clamping the left primary bronchus. The right lobes were lavaged 
using 8 ml of 0.9% sterile saline in a 12 ml syringe, washing with the same aliquot three 
times. The resultant bronchoalveolar lavage fluid (BALF) was collected into 15ml round 
bottom tubes and kept on ice until processed. The right lobes were removed and stored at 
−80°C. The left lobe of most animals was perfused with 4% paraformaldehyde at 30 cm of 
pressure for one hour. There were six animals per treatment at each timepoint tested (N= 6/
group and timepoint).
BALF Macrophages
BALF was centrifuged at 2000 rpm and 4°C for 10 minutes to pellet cells. The supernatant 
was removed and the cell pellet was resuspended in 2 ml sterile 0.9% saline and the total 
number of cells and non-viable cells, using Trypan blue assay, were counted. Cytospin 
slides were prepared from the resuspended BALF cells for silver staining and quantitation of 
macrophages as a percentage of the total cells.
Silver Staining
Two 1 mm blocks representing short and long axial path airways of the 4% 
paraformaldehyde fixed left lobe were embedded in paraffin and sectioned onto poly-L-
lysine coated slides. Silver was visualized using a variation of a published method for 
autometallography (Danscher, 2006, Hacker, 1988). A silver enhancement kit for light and 
electron microscopy (Ted Pella Inc, Redding CA) was used (Wang, 2014) and all slides 
were developed under identical conditions to facilitate comparisons across groups and 
timepoints. Paraffin embedded samples were deparafinized, rehydrated and stained with 
equal volumes of enhancer and developer for 15 minutes. Cytospin slides were hydrated in 
PBS, stained for silver as described above and then lightly counter stained with diluted 
1:1000 methylene blue azure II stain.
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The percentage of silver-positive BALF macrophages was determined in cytospins stained 
by autometallography and counted for silver positive and negative macrophages at 40× 
magnification. A total of 500 cells were counted per slide. To further assess the silver load 
in the macrophage population, a semi-quantitative scoring system was employed. Silver-
positive macrophages were subdivided into light, moderate and heavy staining for silver as 
shown in Figure S1. Two hundred silver positive macrophages were scored per animal; all 
silver positive macrophages were scored if less than 200 macrophages were silver positive. 
The determined fractions of light, moderate and heavy silver content macrophages were 
used to determine a score for each animal using the formula:
where S is the silver score, MT is the total recovered macrophages per ml of BALF, and fL, 
fM and fH are the fractions of silver positive macrophages in the macrophage population.
TEM of BALF Macrophages—Cells recovered from BALF were fixed with Karnovsky’s 
fixative (0.9% glutaraldehyde/0.7% paraformaldehyde in cacodylate buffer, adjusted to pH 
7.4, 330 mOsmol/kgH2O) and suspended in agar blocks. Blocks were embedded in Araldite 
502 resin and osmicated (Van Winkle, 1995). Sections were cut using a Leica Ultracut UCT 
ultramicratome and Diatome diamond knives. TEM images of BALF macrophages were 
obtained using a Philips CM120 electron microscope.
Silver deposition quantification
Concentration of silver in the right middle lobe was determined using ICP-MS on the snap 
frozen right middle lobe stored at −80°C. The lobes were lyophilized using a Labconco 
FreeZone 2.5 (Kansas City, MO) freeze drying system and weighed to determine tissue dry 
weight. Tissue was digested with 70% trace metal grade nitric acid (Fisher, Pittsburg, PA) 
and heated to 70°C for two hours. Samples were cooled to room temperature, an equal 
volume of 30% H2O2 was added. Samples were reheated to 70°C for 2-4 h to break down 
remaining lipids and finally cooled to room temperature and diluted 10:1 with 3% HNO3 for 
analysis by the UC Davis/Interdisciplinary Center for Plasma Mass Spectrometry using an 
Agilent 7500CE ICP-MS (Agilent Technologies, Palo Alto, CA) (Abid, 2013). The samples 
were introduced using a MicroMist Nebulizer (Glass Expansion, Pocasset, MA) into a 
temperature controlled spray chamber with Helium as the collision cell gas. Instrument 
standards were diluted from Certiprep Ag Standard (SPEX CertiPrep, Metuchen, NJ) to 
0.5ppb, 1ppb, 10ppb, 50ppb, 100ppb, 200ppb, and 500ppb respectively in 3% Trace 
Element HNO3 (Fisher) in 18.2 MΩ-cm water. A NIST 1643E Standard (National Institute 
of Standards and Technology, Gaithersburg, MD) was analyzed initially and QC standards 
consisting of a Certiprep Ag Standard at a concentration of 100ppb was analyzed every 12th 
sample as a quality control. Sc, Y, and Bi Certiprep standards (SPEX CertiPrep) were 
diluted to 100ppb in 3% HNO3 and introduced by peripump as an internal standard.
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The level of silver present in the terminal bronchioles of the left lung lobe was assessed 
using a semi-quantitative scoring system (Coppens, 2007). Silver enhanced stained slides 
were blinded and scored on a scale of zero to four using the criteria described in 
Supplemental Table 1. All terminal bronchioles in the two pathway sections were scored and 
the mean was taken to represent that animal. Six animals were counted per group.
Statistics
Data are reported as mean ± standard error of the mean (SEM) unless otherwise stated. 
Statistical outliers were eliminated using the extreme deviate method (Graphpad, La Jolla, 
CA). Multivariate analysis of variance (MANOVA) was applied against particle size, 
surface coating, time-point and dose when appropriate. Multiple comparisons for factors 
containing more than two levels were performed using Fisher’s Protected Least Significant 
Difference (PLSD) method. Pair-wise comparisons were performed individually using a 
one-way ANOVA followed by PLSD post hoc analysis. Non-parametric data analysis was 
performed using a Kruskal-Wallis ANOVA and Median test or a Mann-Whitney test where 
appropriate. p values of < 0.05 were considered statistically significant. Statistics was 
performed using STATISTICA 64 (Tulsa, OK).
RESULTS
Particle Characterization
All AgNPs were supplied by the NIEHS NCNHIR and NCI and were previously 
characterized (Wang, 2014). TEMs of both sizes of particles (Figure S2) in suspension at the 
time of instillation indicate AgNP of the expected sizes. Some particle clumping in 
suspension is expected. DLS confirmed that sonication just prior to instillation results in 
single particles of the expected size. The diameter of the 110 nm citrate AgNP was 108.5 nm 
and the 20 nm citrate was 19.5 nm. These results are in agreement with other studies using 
the same particles and resuspension methods (Wang, 2014). It should be noted that these are 
measures of the core silver particle size and protein corona and surface modifications could 
add to this size.
Macrophage clearance of AgNP
BALF cells were tested for viability and the percentage of non-viable cells was not different 
between the control (range of 1.2-2.2%) and exposed (range of 2.3-3.5%) groups. BALF 
cells were stained for silver content and the predominant BALF cell type that contained 
silver as determined by autometallography was the macrophage population (Figure S1). 
Within this population, there were a variety of macrophage profiles with the majority of 
profiles containing no silver stain (Figure S1B) and the remainder containing various 
amounts of silver (Figure S1A-D). These profiles were similar between all 4 particle types. 
Some macrophages were loaded with silver and had a foamy appearance (Figure S1D). 
When total macrophage cell numbers were examined (Figure 1A, C, E and G), BALF 
macrophages were increased following instillation of AgNPs but the temporal pattern of this 
increase, as well as the percentage of BALF macrophages containing silver (Figure 1B, D, F 
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and H) varied with particle size and coating. The smaller 20 nm AgNPs were more effective 
at increasing macrophage numbers at either 1 or 7 days following exposure than the 110 nm 
particles. Only the 20nm citrate AgNP resulted in statistically significant increases in 
macrophage numbers in lavage that persisted to 21 days post exposure (Figure 1A) as all 
other groups returned to control values by 21 days (Figure 1C, E and G). Only the 110nm 
citrate AgNP was not able to induce an acute increase in macrophage cell numbers at 1 days 
post exposure (Figure 1C). By 24 h, the percentage of macrophages that were positive for 
silver varied from a high of 38% in the 110 nm PVP group to a low of 22% in the 110 nm 
citrate group, but all particle exposures resulted in detection of silver positive macrophages 
(Figure 1B, D, F and H). Instillation of 1.0 mg/kg of the 20 nm citrate coated AgNP 
produced the greatest percentage of silver positive macrophages persisting to 21 days post 
exposure (Figure 1B). Interestingly, this was significantly greater than in the group exposed 
to the same size particles but with a PVP coating (Figure 1F). There was not a difference in 
the percentage of positive macrophages with increasing dose except for the 20nm citrate 
AgNP at 21 day (p = 0.049), where the 1.0 mg/kg dose was significantly higher than the 0.5 
mg dose at that timepoint (Figure 1B).
To assess the differences in internalized silver in the macrophage population, we created a 
silver uptake score (Figure 2). This system gives greater weight to macrophages staining 
heavily for silver resulting in higher scores in treatment groups with a high percentage of 
heavily stained macrophages. This more clearly delineates that the 20nm citrate coated 
particles have the greatest degree of macrophage involvement 21 days post exposure (Figure 
2A). Additionally, uptake of AgNPs was demonstrated in TEM micrographs of macrophages 
containing particles (Figure 3). A 110 nm AgNP located in a vacuole in Figure 3A and 3B 
(open arrow). Figure 3C shows a different macrophage with a silver particle in a lysosome.
Localization of silver in lung tissue
The abundance of silver and distribution of AgNPs was determined in lung tissue using ICP-
MS on the right middle lung lobe and autometallography on tissue sections from the left 
lung lobe of the same animals. Surface coating of the AgNPs had the largest effect on silver 
clearance from the tissue with PVP coated AgNPs showing significant clearance of 20 nm 
AgNP (p = 0.013) and 110 nm AgNP nearly significant (p = 0.078) at 21 days after exposure 
(Figure 4). There was no difference in particle clearance by particle size. Interestingly, there 
was a lack of significant clearance of both citrate coated AgNPs even at 21 days after a 
single acute exposure, although there was quite a bit of variance in these measurements with 
a range from 0 to 1.6 μg/g in the 20 nm citrate and a range of 0 to 2.8 μg/g in the 110 nm 
citrate. The following decreases in measured silver were observed at 21 days when 
compared to lobes containing particles of the same size 1 day after instillation: 2% for the 20 
nm citrate, 91% for the 20 nm PVP, 9% for the 110 nm citrate and 71% for the 110 nm PVP.
Examination of the intrapulmonary lobar bronchus of the left lobe indicated that at 1 day 
post exposure, the 110 nm AgNP were removed from the larger airways more completely 
than the 20nm AgNP (compare Figure 5B and D with Figure 5A and C). The silver was 
heavily localized to the surface epithelium and was found on the cilia as well as within Clara 
cells and this intracellular localization was especially prominent for the citrate coated 
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AgNPs (Figure 5A). At the same time point (1 day post exposure), silver was intensely 
localized to the most distal conducting airways, the terminal bronchioles, and the 
immediately adjacent bronchoalveolar regions in all groups (Figure 6A, C, E and G). Silver 
was localized to the surface epithelial cells including dark intracellular staining in Clara cells 
(Figure 6B, D, F, and H) and was also found in the subepithelial basement membrane zone. 
Subepithelial localization to the basement membrane zone was especially prominent in the 
20nm citrate and 20nm PVP groups (Figure 6B and F). All groups had intense staining of 
tissue macrophages associated with the basement membrane zone, however, the silver 
staining was less abundant for the larger 110 nm AgNPs (Figure 6C and G) compared to the 
20 nm AgNPs (Figure 6A and E).
At 7 days post exposure (Figure 7A-H), silver was heavily localized to the basement 
membrane zone of the terminal bronchioles, alveolar macrophages and immediately adjacent 
alveoli of the bronchoalveolar duct junction. This was the only region of the lung that 
contained heavy staining at this timepoint; the larger airways and more peripheral alveoli did 
not contain detectable silver (Figure S3). Silver was also localized to the vascular 
endothelium in this region (Figure 8F). In contrast to 1 day post exposure, the epithelium of 
the most distal portion of the terminal bronchiole no longer contained large accumulations of 
silver (compare Figure 6 with Figure 7). This staining pattern was similar between AgNPs of 
different sizes and surface coatings. However, some cells in the more proximal portion of 
the terminal bronchiole, contained silver accumulations in the epithelium and this included 
both cytoplasmic and nuclear staining of Clara and ciliated cells (Figure S4). Frank 
epithelial cytotoxicity was not seen in the high resolution histopathology for any timepoint 
or type of AgNPs (data not shown). At 21 days post exposure (Figure S5), silver was still 
detectable in focal areas of some of the terminal bronchioles. The few areas of the terminal 
bronchiole/alveolar duct region that did have localized staining at this timepoint are shown 
in Figure S5. There was not a difference in the abundance of these regions by particle type. 
Silver was also found in tissue macrophages but was greatly diminished in all groups 
compared to the pattern at 1 and 7 days. To give an assessment of the range of staining 
within the tissue, we used a semiquantitative scoring method to illustrate overall tissue 
terminal bronchiole/alveolar duct junction staining intensity by days after exposure (Figure 
8). This illustrates the significant reduction in silver localization in this lung region by 21 
days after exposure in all the exposure groups.
DISCUSSION
We tested AgNPs of two sizes (110 vs 20 nm) and two surface coatings (citrate vs PVP) at 
two doses (0.5 and 1.0 mg/kg) in adult male rats. Our results show that AgNPs and/or silver 
in some form, persists in the lungs as long as 21 days following a single acute i.t. exposure. 
Further, particle size has a modest effect on the amount retained in the lung tissue but 
particle coating heavily influences the retention of silver in the lung at 21 days. The PVP 
coated material cleared more quickly than the citrate coated material. Macrophages were 
heavily involved in clearance of the material, especially the 20 nm citrate coated material, 
even at 21 days following a single acute exposure.
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There is debate about the constituents or chemical state of AgNP that contributes to their 
health effects (Behra, 2013). It is not clear whether it is the silver ions released from the 
AgNP (Wang, 2014), or the AgNP themselves, that cause adverse health effects (Cronholm, 
2013, Beer, 2012, Gliga, 2014). Our study was not designed to define whether the silver in 
the lung was ionic, but rather to probe whether the AgNP we added to the lungs of rats 
persisted in the lung, as any form of silver, over time. Recent work using the same AgNPs 
(Wang, 2014) found that 20 nm particles, regardless of coating, shed a greater amount 
(~4%) of silver ion into BEGM medium in vitro than larger particles. We note that 
measurement of release of silver ions from nanomaterials into tissues in vivo has not been 
accomplished to date and may have different kinetics than in vitro systems. Some inference 
may be made from other studies of silver nanoparticles and soluble silver ions. In a study in 
rats rat study, instilled ionic silver (AgN03) was found to be rapidly cleared in contrast to 
instilled ultrafine silver particles with only 25% of the day one ionic lung dose remaining in 
the lung at 7 days (Takenaka, 2001). Silver ion binding to proteins was thought to be a 
potential mechanism for retention of ions as long as 7 days. A study by Wang et al used the 
same particles as in the current study and found that significant less AgN03 was retained 40 
hours after exposure than either the 20 nm or 110 nm AgNP (Wang, 2014) and that AgN03 
administered silver was undetectable in the mouse lung 21 days after exposure in contrast to 
significant persistence of AgNP silver as measured by ICP-MS. In this study we performed 
autometallography on lung samples 1 day post treatment with AgNO3 (see supplementary 
materials). At 1 day post exposure the pattern of staining in the AgNO3 differed 
considerably, with very diffuse and spotty staining (Figure S6). The autometallographic and 
ICP-MS methods we used do not discriminate between ionic and particle bound silver. 
Autometallography is most likely to detect areas of heavy silver localization and less likely 
to detect diffuse accumulations throughout the tissue. Further, the staining protocol was 
optimized to detect staining at 1 day post exposure and the same development practices were 
used for all the timepoints in this study to facilitate comparisons. This may be why the 
autometallography detects little silver at 21 days post exposure but the ICP-MS 
measurement indicates that significant silver persists in the lung at this timepoint. If the 
smaller particles have higher dissolution rates in vivo, as has been demonstrated in vitro 
(Wang, 2014), this could be related to the observed increased deposition of silver in the 
subepithelial basement membrane zone that was noted for the 20nm particles at 1 day after 
exposure (Figure 7).
Macrophages play a critical role in particle clearance in the lung. A study of 25nm inhaled 
titanium dioxide found that macrophages had sporadic uptake of particles at 24 h after 
exposure (Geiser, 2008), indicating that phagocytosis of nanometer-sized particles is fairly 
inefficient (Geiser, 2010). Other studies have indicated that smaller magnetite (Fe3O4) 
nanoparticles (10nm) are less potent at inducing macrophage influx into the lung than larger 
50 nm particles (Katsnelson, 2010). In addition, studies of gold nanoparticles of 3 sizes (2, 
40 and 100 nm) given by intratracheal instillation found that lung macrophages have very 
rapid uptake of particles with instilled nanoparticles already localized to macrophages 1h 
after a single instillation and localized to macrophage lysosome-like vesicles (Sadauskas, 
2009). Other studies of intratracheally instilled silver have also noted macrophage 
accumulation of silver nanoparticles in phagolysosomes of alveolar macrophages 
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(Takenaka, 2001). Our data indicate similar findings; macrophages are involved in 
scavenging silver or silver NP at all timepoints examined and the intracellular localization of 
the silver was to lysosome-like vesicles. In general, the smaller silver particles induced a 
greater maximal measured macrophage influx than the larger ones. This may be related to 
the composition or number of the particles. A dose of 1.0 mg/kg instilled in the average 
weight rat from this study (359.5 g) would be equal to 1.45×1016 particles/rat for the 20 nm 
AgNP and 8.74×1013 particles/rat for the 110 nm AgNP. The number of 20 nm particles 
instilled in rats is 166 times greater than the 110 nm particles. While particle type did not 
influence macrophage influx into BALF at 1 day post exposure, the 1 mg/kg dose 110 PVP 
AgNP macrophage silver score was significantly higher than the 110 nm citrate AgNP 
indicating a difference by particle coating. We found that the 20nm citrate particles had the 
highest macrophage silver score at 21 days after exposure. This may be due to a higher 
number of smaller particles being present in the sub-alveolar regions, greater bioavailability 
of these particles or differences in particle shedding of ions.
Particles that deposit in the large airway are removed through the mucociliary escalator and 
this is still occurring at 1 day but is diminished at 7 days post exposure (Figure S3). This 
mechanism is an effective the early response for removal of the larger particles. One study 
using insoluble particles of 0.1, 1, 2 and 7 μm found the mucociliary clearance halftime for 
rats is 1.25 h (Hofmann, 2003). In contrast, a study using 15 nm iridium (Ir) particles found 
18% clearance into the gastrointestinal tract after 6 h (Kreyling, 2002). This suggests that 
clearance of smaller nanoparticles is slower. However, a recent study by Kreyling et al 
found that there was large variability in mucociliary cleared AuNP fraction at 24 hours both 
between animals (n=4) and with particles of different sizes with the largest variance noted 
for particles that were 1.4 nm (Kreyling, 2014). However, their variance for the larger 
particles was less and is in good agreement with our current data (n=6). Our current study 
that shows persistence of the smaller (20nm) silver particles in the lung is in agreement with 
other studies that show that smaller particles are more efficiently translocated to interstitial 
spaces and are slower to clear (Kreyling, 2002). Thus, while macrophage numbers are 
increased in response to all four particle types, there is a different temporal pattern by 
particle type with the smaller particles inducing an early increase in BALF macrophages at 
the lower 0.5 mg/kg dose at 1 day post exposure, possibly due to their larger surface area. 
However, we note that due to the 6 day period between our first two sampling points we 
cannot rule out that other exposure groups may have had a peak macrophage influx that we 
did not detect.
Macrophages have a substantial role in scavenging the silver present in the distal lung even 
21 days following the initial particle exposure. This is evident from the detectable levels of 
silver containing macrophages in the BALF of all exposure groups. However, only one of 
the particle types tested, the 20nm citrate coated AgNP, still induced a significant increase in 
BALF macrophages at 21 days after exposure. Notably this was also the exposure group 
with the highest percentage of silver positive macrophages at 21 days. Interestingly there 
were not large differences in macrophage numbers or numbers of positive macrophages by 
dose, with the exception of the 20nm citrate AgNP at 21 days post exposure, possibly 
indicating a maximum for macrophage mediated removal at these two doses in the lung.
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Our study found that instilled AgNPs result in silver accumulation in the lung tissue itself 
both within the epithelium acutely as well as within macrophages and in the subepithelial 
basement membrane zone. The accumulation at 1 day followed by clearance of the silver 
from Clara cells at 7 days may indicate an active role for Clara cells in nanoparticle 
processing. Clara cells have previously been reported to endocytose surfactant protein D into 
secretory granules located at the apex of the cell (Voorhout, 1992). This is in agreement with 
in vitro studies of other lung epithelial cells (BEAS-2B) that showed accumulation of 
AgNPs over 24 h (Wang, 2014, Gliga, 2014) and preferential accumulation of AgNPs versus 
a soluble silver salt in vitro (Cronholm, 2013, Wang, 2014). This raises several interesting 
questions: why does the silver accumulate in the subepithelial basement membrane zone at 7 
days post exposure and is it still confined to AgNPs at this time? There are several 
possibilities: the epithelial cells could secrete the particles or the silver ions basolaterally, 
the components of the basement membrane zone could preferentially sequester the silver or 
the particles, or possibly the AgNP distribution is fairly uniform throughout the lung initially 
but the basement membrane zone is a difficult area to clear of nanosilver or its ions. A 
similar staining pattern was found in the parallel mouse studies and correlated with the 
expression of basement membrane collagen (Wang, 2014). In contrast to Wang et al, the 
subepithelial silver staining in the current rat study resolved by 21 days post exposure. This 
may indicate removal by macrophages or turnover of the molecules binding silver. Other 
studies report silver sequestration to supepithelial basement membranes in the skin 
following silver dietary supplement intake (Bowden, 2011). A study of silver ion release 
from implanted silver surfaces noted accumulation of silver in lysosome-like organelles and 
associated with collagen fibers in the basement membrane of multiple organs (Danscher, 
2010). It remains to be determined which molecules preferentially bind either AgNP or Ag 
ions in the basement membrane zone of the lung and the precise subcellular localization of 
the silver.
The doses used in this study are comparable to a similar study using the same particles in 
mice (Wang, 2014). These doses were selected to model an environmental exposure (5-289 
ug/m3) that occurred in a manufacturing facility (Lee, 2012) and to facilitate cross species 
comparisons. In Wang et al both sizes of the citrate coated AgNPs cleared similarly 
(approximately 60%) over the period of 2-21 days post a single acute exposure in mice. Our 
measured clearance rate for the same particles between 1 and 21 days post exposure in rats 
was clearly less (25-50%) and also did not show a significant decrease with time post 
exposure, indicating a possible species difference in response for the citrate coated particles. 
This may be partially due to the fact that the right middle lung lobe was lavaged before 
freezing and so our measurements of silver retention only account for that which was still 
incorporated in the tissue itself. However, the fraction of lavagable particles is likely to be 
small, as demonstrated in a study of 20 nm 192Ir particles that found only 14% of the 
particles were in the lavage 24 h after exposure (Semmler-Behnke, 2007). This supports the 
thought that particles rapidly associate with lung tissue. Interestingly, our measured PVP 
clearance data found greater than 75% clearance between 1 and 21 days post exposure, on 
par with the data reported by Wang et al for citrate particles in mice (they did not report 
PVP clearance). Clearly there is preferential clearance of PVP coated particles compared to 
citrate coated particles in our rat model. Further, we can relate our clearance from the lung 
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tissue for all 4 particle types in terms of the percentage of the initial delivered dose of each 
particle size with 2% and 91% clearance of 20 nm citrate and PVP AgNPs respectively and 
9% and 71% for citrate and PVP 110 nm AgNPs respectively. Previous studies of 
fluorescent 20 nm and 100nm polystyrene spheres found that the 20 nm spheres have a 
greater propensity to stay in the body (Sarlo, 2009). A study of aerosolized and instilled 
ultrafine 192Ir particles at either 15 or 80 nm in rats showed that most particles stayed in the 
lung at 7 days (Kreyling, 2002) in agreement with our current study.
It is important to keep in mind that, while useful for directly comparing doses of compound 
and screening large numbers of compounds quickly, instillation exposure of AgNP in liquid 
has limitations in regards to health assessment of possible environmental exposure to an 
aerosol of dry or aqueous material. The retention pattern could be different because 
deposition pattern is different; other studies show that clearance of instilled particles is 
slower than that of comparable particles that are inhaled (Driscoll, 2000). Whether retention 
of inhaled AgNP is similar needs to be determined in future studies of inhaled particles of 
the same type. Instillation can result in a non-uniform distribution between lung lobes. Our 
staining studies using autometallography for the left lung lobe support a uniform distribution 
of the silver within the lobe with consistent deposition in similar regions, including 
bronchiolar alveolar duct junctions, throughout the lung regardless of particle type. 
However, the distribution to other lobes, especially those such as the right middle lung lobe, 
which we used for the ICP-MS measurements, may be less uniform. This is supported by the 
amount of variance in the ICP-MS data from this lobe (Figure 4). We note that, even with 
the measured variance, there was sufficient power to detect a decrease in silver content of 
the lung for the PVP coated particles at 21 days post exposure.
CONCLUSION
In conclusion our study shows that silver associated with PVP coated particles is most 
efficiently cleared from the lung at 21 days following acute exposure and that the 20nm 
citrate coated AgNP result in the greatest amount of silver still present in the lungs at 21 
days. In general, persistence of silver in the lung correlated with increased BALF 
macrophages and higher percentages of silver positive BALF macrophages. As early as 1 
day following exposure, differences in particle removal were apparent with the 110 nm 
particles more efficiently removed from the larger airways. The current study supports a 
large effect of particle surface coating on both persistence and biological effect (macrophage 
recruitment and involvement), with a lesser effect of particle size.
Supplementary Material
Refer to Web version on PubMed Central for supplementary material.
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Total macrophages (A, C, E and G) and percentage of silver positive macrophages (B, D, F 
and H). in BALF 1, 7 or 21 days after i.t. instillation of 4 types of silver nanoparticles of two 
doses (0.5 and 1.0 mg/kg). (A, B) 20nm citrate, (C, D) 110nm citrate, (E, F) 20nm PVP and 
(G, H) 110nm PVP. * significantly greater than control at same time-point (p < 0.05). † 
significantly different from same dose at 1 day time point (p < 0.05) (n = 6) NT = not tested.
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BALF Macrophage silver uptake scores. Macrophages were scored based on intensity of 
silver staining (light, moderate or heavy) as shown in Figure S1 and adjusted for the total 
number of silver positive macrophages that were recovered from BALF to generate a 
macrophage silver uptake score for each treatment group and timepoint. * significantly 
different than 1 d time-point for same AgNP size, coating and dose, † significantly 
difference between citrate and PVP coated AgNP at same timepoint, AgNP size and dose, ‡ 
significantly difference between 20nm and 110nm AgNP at same timepoint, AgNP coating 
and dose (p < 0.05) (n = 5-6).
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TEM image of macrophages containing silver particles. An (A) overview and (B) detail of a 
AgNP (open arrow) in a vacuole of a macrophage recovered from BALF. (C) An example of 
a AgNP (open arrow) in the lysosome of a BALF recovered macrophage.
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Silver quantification in the right middle lung lobe by ICP-MS following 1.0 mg/kg dose of 
AgNPs. (A) is 20nm AgNPs treated animals and (B) is 110nm treated animals. Black bars 
are PVP coated AgNPs and grey bars are citrate coated AgNPs. * significantly different than 
1 d time-point for same AgNP size and coating (p <0.05) (n = 6).
Anderson et al. Page 19














Autometallography (dark staining) of silver localization on and within the epithelium of the 
proximal airways (intrapulmonary lobar bronchus) 1 day post exposure to 1.0 mg/kg 
AgNPs. (A) 20nm citrate, (B) 110nm citrate, (C) 20nm PVP and (D) 110nm PVP. Note the 
staining on the ciliated cell (arrows) as well as within Clara cells (arrowheads) Bars = 50μm.
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Autometallography (dark staining) of silver localization in the terminal bronchiole alveolar 
duct junction at 1 days post exposure to 1.0 mg/kg AgNPs. (A, B) 20nm citrate, (C, D) 
110nm citrate, (E, F) 20nm PVP and (G, H) 110nm PVP. Clara cells (arrowheads) and 
macrophages (arrows) as well as the subepithelial basement membrane zone (open arrows) 
contained silver. Bars = 50μm.
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Autometallography (dark staining) of silver localization to the terminal bronchiole alveolar 
duct junction at 7 day post exposure to 1.0 mg/kg AgNPs. (A, B) 20nm citrate, (C, D) 
110nm citrate, (E, F) 20nm PVP and (G, H) 110nm PVP. Macrophages (arrows), basement 
membrane zone (open arrows), alveolar walls (arrowheads) and vessels (V) contained heavy 
localization of silver. Clara cells were not stained. Bars = 50μm.
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Semi-quantitative scoring of silver distribution in the terminal bronchiole region. (A) 20 nm 
citrate, (B) 110 nm citrate, (C) 20 nm PVP and (D) 11 0nm PVP. * significantly less than 1 
Day post treatment (p < 0.05), † significantly less than 7 days post treatment (p < 0.05) (n = 
6).
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